Alnylam Pharmaceuticals (ALNY.MX) Q3 2014 Earnings

7AugConfirmed
Q4 2013
Q1 2014
Q2 2014
Q3 2014
-7.72
-6.83
-5.94
-5.05

Details

Expected EPS
-7.450184000000001
Actual EPS
-7.7162619999999995
Surprise EPS
-0.27
Surprise Percent
+3.57%

Description

Alnylam Pharmaceuticals (ALNY.MX) has reported earnings of -7.7162619999999995 per share for Q3 2014.

0 Comments

Share your thoughts